Frontiers in Oncology-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=2179063, encodeId=e3ea21e906379, content=偏重的研究方向：肿瘤 经验分享：这期刊最近submit多久拒稿呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=152e5448879, createdName=ms4000001668897773, createdTime=Wed Jan 03 17:03:30 CST 2024, time=2024-01-03, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2175546, encodeId=1f0021e5546ce, content= 审稿人的回复：I strongly believe if the authors attempt a rewrite sentence by sentence and consider grammar the quality of the work will be improved tremendously and it will be useful article to scientific community everywhere. In its current form, I am not able to recommend this article for publication.这是拒了的意思吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dbde5575440, createdName=ms8000000268717089, createdTime=Mon Dec 18 09:37:50 CST 2023, time=2023-12-18, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2178638, encodeId=c9ba21e86387a, content=偏重的研究方向：肿瘤 经验分享：23.12.27 submit 24.1.1 仍然initial validation, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=152e5448879, createdName=ms4000001668897773, createdTime=Mon Jan 01 18:38:20 CST 2024, time=2024-01-01, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2160922, encodeId=32312160922ec, content=技术审查一个多月了，催了几次都说会催诚信团队，但至今都卡在技术审查这步，有人遇到过同样情况吗😮‍💨, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=009a8811870, createdName=ms1000000556586108, createdTime=Wed Oct 04 17:16:56 CST 2023, time=2023-10-04, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2174385, encodeId=9bf921e43850a, content=各位老师号！请教一个问题：这个杂志上的文章published之后多长时间可以在web of science检索到？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5b1f5387570, createdName=ms7000002110969436, createdTime=Tue Dec 12 08:59:12 CST 2023, time=2023-12-12, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2159908, encodeId=15552159908be, content=投稿时就要付款了吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8c7a8160924, createdName=ms5000001590163843, createdTime=Tue Sep 26 23:25:07 CST 2023, time=2023-09-26, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2148854, encodeId=489b214885495, content=审稿速度:3.0 偏重的研究方向：seer数据库;肿瘤 经验分享：投稿经验分享：总共三个审稿人，其中第2个审稿人拒稿，审稿人1和3分别给了大修意见，2周时间修回，审稿人1和3均很快finalized。然后编辑10天左右接收，感恩编辑处理速度，虽说影响因子有降，但还是很开心，希望大家都投稿顺利，遇到nice的编辑和审稿人~ 07 Apr 2023 Submitting Author submitted manuscript. 16 Jun 2023 Interactive review forum activated automatically. 30 Jun 2023 Review of Review Editor 3 finalized. 09 Jul 2023 Review of Review Editor 1 finalized. 18 Jul 2023 Article accepted for publication., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=117, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=57b84693922, createdName=gaogao, createdTime=Wed Jul 19 21:10:43 CST 2023, time=2023-07-19, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2170093, encodeId=1f9021e009306, content=偏重的研究方向：肿瘤免疫 经验分享：这个杂志未来预警的可能性大吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6a638109651, createdName=清清欢, createdTime=Tue Nov 21 22:48:23 CST 2023, time=2023-11-21, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2167854, encodeId=4120216e85470, content=审稿速度:1.0 | 投稿命中率:95.0 偏重的研究方向：肺癌 经验分享：非常快！ 27 Sep 2023 Article accepted for publication. Submitting Author re-submitted manuscript. 25 Sep 2023 Corresponding/Submitting Author is automatically requested to revise and resubmit the manuscript. Review of Reviewer 2 is finalized. Review of Reviewer 1 is finalized. 13 Sep 2023 Submitting Author submitted manuscript., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5bca6432300, createdName=ms4000000828277451, createdTime=Fri Nov 10 15:07:18 CST 2023, time=2023-11-10, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2167075, encodeId=f43d216e07557, content=目前只邀请到了一个审稿人，且这个审稿人审稿结束了，同意出版。编辑说还要邀请审稿人呢，一个审稿人不行，已经过去半个月了，还没消息。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5b1f5387570, createdName=ms7000002110969436, createdTime=Mon Nov 06 19:23:30 CST 2023, time=2023-11-06, status=1, ipAttribution=江苏省)]

2024-01-03 ms4000001668897773 来自北京

偏重的研究方向：肿瘤
经验分享：这期刊最近submit多久拒稿呢？

33 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2179063, encodeId=e3ea21e906379, content=偏重的研究方向：肿瘤 经验分享：这期刊最近submit多久拒稿呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=152e5448879, createdName=ms4000001668897773, createdTime=Wed Jan 03 17:03:30 CST 2024, time=2024-01-03, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2175546, encodeId=1f0021e5546ce, content= 审稿人的回复：I strongly believe if the authors attempt a rewrite sentence by sentence and consider grammar the quality of the work will be improved tremendously and it will be useful article to scientific community everywhere. In its current form, I am not able to recommend this article for publication.这是拒了的意思吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dbde5575440, createdName=ms8000000268717089, createdTime=Mon Dec 18 09:37:50 CST 2023, time=2023-12-18, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2178638, encodeId=c9ba21e86387a, content=偏重的研究方向：肿瘤 经验分享：23.12.27 submit 24.1.1 仍然initial validation, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=152e5448879, createdName=ms4000001668897773, createdTime=Mon Jan 01 18:38:20 CST 2024, time=2024-01-01, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2160922, encodeId=32312160922ec, content=技术审查一个多月了，催了几次都说会催诚信团队，但至今都卡在技术审查这步，有人遇到过同样情况吗😮‍💨, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=009a8811870, createdName=ms1000000556586108, createdTime=Wed Oct 04 17:16:56 CST 2023, time=2023-10-04, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2174385, encodeId=9bf921e43850a, content=各位老师号！请教一个问题：这个杂志上的文章published之后多长时间可以在web of science检索到？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5b1f5387570, createdName=ms7000002110969436, createdTime=Tue Dec 12 08:59:12 CST 2023, time=2023-12-12, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2159908, encodeId=15552159908be, content=投稿时就要付款了吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8c7a8160924, createdName=ms5000001590163843, createdTime=Tue Sep 26 23:25:07 CST 2023, time=2023-09-26, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2148854, encodeId=489b214885495, content=审稿速度:3.0 偏重的研究方向：seer数据库;肿瘤 经验分享：投稿经验分享：总共三个审稿人，其中第2个审稿人拒稿，审稿人1和3分别给了大修意见，2周时间修回，审稿人1和3均很快finalized。然后编辑10天左右接收，感恩编辑处理速度，虽说影响因子有降，但还是很开心，希望大家都投稿顺利，遇到nice的编辑和审稿人~ 07 Apr 2023 Submitting Author submitted manuscript. 16 Jun 2023 Interactive review forum activated automatically. 30 Jun 2023 Review of Review Editor 3 finalized. 09 Jul 2023 Review of Review Editor 1 finalized. 18 Jul 2023 Article accepted for publication., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=117, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=57b84693922, createdName=gaogao, createdTime=Wed Jul 19 21:10:43 CST 2023, time=2023-07-19, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2170093, encodeId=1f9021e009306, content=偏重的研究方向：肿瘤免疫 经验分享：这个杂志未来预警的可能性大吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6a638109651, createdName=清清欢, createdTime=Tue Nov 21 22:48:23 CST 2023, time=2023-11-21, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2167854, encodeId=4120216e85470, content=审稿速度:1.0 | 投稿命中率:95.0 偏重的研究方向：肺癌 经验分享：非常快！ 27 Sep 2023 Article accepted for publication. Submitting Author re-submitted manuscript. 25 Sep 2023 Corresponding/Submitting Author is automatically requested to revise and resubmit the manuscript. Review of Reviewer 2 is finalized. Review of Reviewer 1 is finalized. 13 Sep 2023 Submitting Author submitted manuscript., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5bca6432300, createdName=ms4000000828277451, createdTime=Fri Nov 10 15:07:18 CST 2023, time=2023-11-10, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2167075, encodeId=f43d216e07557, content=目前只邀请到了一个审稿人，且这个审稿人审稿结束了，同意出版。编辑说还要邀请审稿人呢，一个审稿人不行，已经过去半个月了，还没消息。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5b1f5387570, createdName=ms7000002110969436, createdTime=Mon Nov 06 19:23:30 CST 2023, time=2023-11-06, status=1, ipAttribution=江苏省)]

2023-12-18 ms8000000268717089 来自广东省

审稿人的回复：I strongly believe if the authors attempt a rewrite sentence by sentence and consider grammar the quality of the work will be improved tremendously and it will be useful article to scientific community everywhere. In its current form, I am not able to recommend this article for publication.这是拒了的意思吗？

47 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2179063, encodeId=e3ea21e906379, content=偏重的研究方向：肿瘤 经验分享：这期刊最近submit多久拒稿呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=152e5448879, createdName=ms4000001668897773, createdTime=Wed Jan 03 17:03:30 CST 2024, time=2024-01-03, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2175546, encodeId=1f0021e5546ce, content= 审稿人的回复：I strongly believe if the authors attempt a rewrite sentence by sentence and consider grammar the quality of the work will be improved tremendously and it will be useful article to scientific community everywhere. In its current form, I am not able to recommend this article for publication.这是拒了的意思吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dbde5575440, createdName=ms8000000268717089, createdTime=Mon Dec 18 09:37:50 CST 2023, time=2023-12-18, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2178638, encodeId=c9ba21e86387a, content=偏重的研究方向：肿瘤 经验分享：23.12.27 submit 24.1.1 仍然initial validation, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=152e5448879, createdName=ms4000001668897773, createdTime=Mon Jan 01 18:38:20 CST 2024, time=2024-01-01, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2160922, encodeId=32312160922ec, content=技术审查一个多月了，催了几次都说会催诚信团队，但至今都卡在技术审查这步，有人遇到过同样情况吗😮‍💨, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=009a8811870, createdName=ms1000000556586108, createdTime=Wed Oct 04 17:16:56 CST 2023, time=2023-10-04, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2174385, encodeId=9bf921e43850a, content=各位老师号！请教一个问题：这个杂志上的文章published之后多长时间可以在web of science检索到？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5b1f5387570, createdName=ms7000002110969436, createdTime=Tue Dec 12 08:59:12 CST 2023, time=2023-12-12, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2159908, encodeId=15552159908be, content=投稿时就要付款了吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8c7a8160924, createdName=ms5000001590163843, createdTime=Tue Sep 26 23:25:07 CST 2023, time=2023-09-26, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2148854, encodeId=489b214885495, content=审稿速度:3.0 偏重的研究方向：seer数据库;肿瘤 经验分享：投稿经验分享：总共三个审稿人，其中第2个审稿人拒稿，审稿人1和3分别给了大修意见，2周时间修回，审稿人1和3均很快finalized。然后编辑10天左右接收，感恩编辑处理速度，虽说影响因子有降，但还是很开心，希望大家都投稿顺利，遇到nice的编辑和审稿人~ 07 Apr 2023 Submitting Author submitted manuscript. 16 Jun 2023 Interactive review forum activated automatically. 30 Jun 2023 Review of Review Editor 3 finalized. 09 Jul 2023 Review of Review Editor 1 finalized. 18 Jul 2023 Article accepted for publication., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=117, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=57b84693922, createdName=gaogao, createdTime=Wed Jul 19 21:10:43 CST 2023, time=2023-07-19, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2170093, encodeId=1f9021e009306, content=偏重的研究方向：肿瘤免疫 经验分享：这个杂志未来预警的可能性大吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6a638109651, createdName=清清欢, createdTime=Tue Nov 21 22:48:23 CST 2023, time=2023-11-21, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2167854, encodeId=4120216e85470, content=审稿速度:1.0 | 投稿命中率:95.0 偏重的研究方向：肺癌 经验分享：非常快！ 27 Sep 2023 Article accepted for publication. Submitting Author re-submitted manuscript. 25 Sep 2023 Corresponding/Submitting Author is automatically requested to revise and resubmit the manuscript. Review of Reviewer 2 is finalized. Review of Reviewer 1 is finalized. 13 Sep 2023 Submitting Author submitted manuscript., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5bca6432300, createdName=ms4000000828277451, createdTime=Fri Nov 10 15:07:18 CST 2023, time=2023-11-10, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2167075, encodeId=f43d216e07557, content=目前只邀请到了一个审稿人，且这个审稿人审稿结束了，同意出版。编辑说还要邀请审稿人呢，一个审稿人不行，已经过去半个月了，还没消息。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5b1f5387570, createdName=ms7000002110969436, createdTime=Mon Nov 06 19:23:30 CST 2023, time=2023-11-06, status=1, ipAttribution=江苏省)]

2024-01-01 ms4000001668897773 来自北京

偏重的研究方向：肿瘤
经验分享：23.12.27 submit 24.1.1 仍然initial validation

26 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2179063, encodeId=e3ea21e906379, content=偏重的研究方向：肿瘤 经验分享：这期刊最近submit多久拒稿呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=152e5448879, createdName=ms4000001668897773, createdTime=Wed Jan 03 17:03:30 CST 2024, time=2024-01-03, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2175546, encodeId=1f0021e5546ce, content= 审稿人的回复：I strongly believe if the authors attempt a rewrite sentence by sentence and consider grammar the quality of the work will be improved tremendously and it will be useful article to scientific community everywhere. In its current form, I am not able to recommend this article for publication.这是拒了的意思吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dbde5575440, createdName=ms8000000268717089, createdTime=Mon Dec 18 09:37:50 CST 2023, time=2023-12-18, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2178638, encodeId=c9ba21e86387a, content=偏重的研究方向：肿瘤 经验分享：23.12.27 submit 24.1.1 仍然initial validation, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=152e5448879, createdName=ms4000001668897773, createdTime=Mon Jan 01 18:38:20 CST 2024, time=2024-01-01, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2160922, encodeId=32312160922ec, content=技术审查一个多月了，催了几次都说会催诚信团队，但至今都卡在技术审查这步，有人遇到过同样情况吗😮‍💨, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=009a8811870, createdName=ms1000000556586108, createdTime=Wed Oct 04 17:16:56 CST 2023, time=2023-10-04, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2174385, encodeId=9bf921e43850a, content=各位老师号！请教一个问题：这个杂志上的文章published之后多长时间可以在web of science检索到？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5b1f5387570, createdName=ms7000002110969436, createdTime=Tue Dec 12 08:59:12 CST 2023, time=2023-12-12, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2159908, encodeId=15552159908be, content=投稿时就要付款了吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8c7a8160924, createdName=ms5000001590163843, createdTime=Tue Sep 26 23:25:07 CST 2023, time=2023-09-26, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2148854, encodeId=489b214885495, content=审稿速度:3.0 偏重的研究方向：seer数据库;肿瘤 经验分享：投稿经验分享：总共三个审稿人，其中第2个审稿人拒稿，审稿人1和3分别给了大修意见，2周时间修回，审稿人1和3均很快finalized。然后编辑10天左右接收，感恩编辑处理速度，虽说影响因子有降，但还是很开心，希望大家都投稿顺利，遇到nice的编辑和审稿人~ 07 Apr 2023 Submitting Author submitted manuscript. 16 Jun 2023 Interactive review forum activated automatically. 30 Jun 2023 Review of Review Editor 3 finalized. 09 Jul 2023 Review of Review Editor 1 finalized. 18 Jul 2023 Article accepted for publication., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=117, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=57b84693922, createdName=gaogao, createdTime=Wed Jul 19 21:10:43 CST 2023, time=2023-07-19, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2170093, encodeId=1f9021e009306, content=偏重的研究方向：肿瘤免疫 经验分享：这个杂志未来预警的可能性大吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6a638109651, createdName=清清欢, createdTime=Tue Nov 21 22:48:23 CST 2023, time=2023-11-21, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2167854, encodeId=4120216e85470, content=审稿速度:1.0 | 投稿命中率:95.0 偏重的研究方向：肺癌 经验分享：非常快！ 27 Sep 2023 Article accepted for publication. Submitting Author re-submitted manuscript. 25 Sep 2023 Corresponding/Submitting Author is automatically requested to revise and resubmit the manuscript. Review of Reviewer 2 is finalized. Review of Reviewer 1 is finalized. 13 Sep 2023 Submitting Author submitted manuscript., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5bca6432300, createdName=ms4000000828277451, createdTime=Fri Nov 10 15:07:18 CST 2023, time=2023-11-10, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2167075, encodeId=f43d216e07557, content=目前只邀请到了一个审稿人，且这个审稿人审稿结束了，同意出版。编辑说还要邀请审稿人呢，一个审稿人不行，已经过去半个月了，还没消息。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5b1f5387570, createdName=ms7000002110969436, createdTime=Mon Nov 06 19:23:30 CST 2023, time=2023-11-06, status=1, ipAttribution=江苏省)]

2023-10-04 ms1000000556586108 来自湖南省

技术审查一个多月了，催了几次都说会催诚信团队，但至今都卡在技术审查这步，有人遇到过同样情况吗😮‍💨

72 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=2179063, encodeId=e3ea21e906379, content=偏重的研究方向：肿瘤 经验分享：这期刊最近submit多久拒稿呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=152e5448879, createdName=ms4000001668897773, createdTime=Wed Jan 03 17:03:30 CST 2024, time=2024-01-03, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2175546, encodeId=1f0021e5546ce, content= 审稿人的回复：I strongly believe if the authors attempt a rewrite sentence by sentence and consider grammar the quality of the work will be improved tremendously and it will be useful article to scientific community everywhere. In its current form, I am not able to recommend this article for publication.这是拒了的意思吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dbde5575440, createdName=ms8000000268717089, createdTime=Mon Dec 18 09:37:50 CST 2023, time=2023-12-18, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2178638, encodeId=c9ba21e86387a, content=偏重的研究方向：肿瘤 经验分享：23.12.27 submit 24.1.1 仍然initial validation, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=152e5448879, createdName=ms4000001668897773, createdTime=Mon Jan 01 18:38:20 CST 2024, time=2024-01-01, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2160922, encodeId=32312160922ec, content=技术审查一个多月了，催了几次都说会催诚信团队，但至今都卡在技术审查这步，有人遇到过同样情况吗😮‍💨, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=009a8811870, createdName=ms1000000556586108, createdTime=Wed Oct 04 17:16:56 CST 2023, time=2023-10-04, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2174385, encodeId=9bf921e43850a, content=各位老师号！请教一个问题：这个杂志上的文章published之后多长时间可以在web of science检索到？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5b1f5387570, createdName=ms7000002110969436, createdTime=Tue Dec 12 08:59:12 CST 2023, time=2023-12-12, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2159908, encodeId=15552159908be, content=投稿时就要付款了吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8c7a8160924, createdName=ms5000001590163843, createdTime=Tue Sep 26 23:25:07 CST 2023, time=2023-09-26, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2148854, encodeId=489b214885495, content=审稿速度:3.0 偏重的研究方向：seer数据库;肿瘤 经验分享：投稿经验分享：总共三个审稿人，其中第2个审稿人拒稿，审稿人1和3分别给了大修意见，2周时间修回，审稿人1和3均很快finalized。然后编辑10天左右接收，感恩编辑处理速度，虽说影响因子有降，但还是很开心，希望大家都投稿顺利，遇到nice的编辑和审稿人~ 07 Apr 2023 Submitting Author submitted manuscript. 16 Jun 2023 Interactive review forum activated automatically. 30 Jun 2023 Review of Review Editor 3 finalized. 09 Jul 2023 Review of Review Editor 1 finalized. 18 Jul 2023 Article accepted for publication., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=117, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=57b84693922, createdName=gaogao, createdTime=Wed Jul 19 21:10:43 CST 2023, time=2023-07-19, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2170093, encodeId=1f9021e009306, content=偏重的研究方向：肿瘤免疫 经验分享：这个杂志未来预警的可能性大吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6a638109651, createdName=清清欢, createdTime=Tue Nov 21 22:48:23 CST 2023, time=2023-11-21, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2167854, encodeId=4120216e85470, content=审稿速度:1.0 | 投稿命中率:95.0 偏重的研究方向：肺癌 经验分享：非常快！ 27 Sep 2023 Article accepted for publication. Submitting Author re-submitted manuscript. 25 Sep 2023 Corresponding/Submitting Author is automatically requested to revise and resubmit the manuscript. Review of Reviewer 2 is finalized. Review of Reviewer 1 is finalized. 13 Sep 2023 Submitting Author submitted manuscript., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5bca6432300, createdName=ms4000000828277451, createdTime=Fri Nov 10 15:07:18 CST 2023, time=2023-11-10, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2167075, encodeId=f43d216e07557, content=目前只邀请到了一个审稿人，且这个审稿人审稿结束了，同意出版。编辑说还要邀请审稿人呢，一个审稿人不行，已经过去半个月了，还没消息。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5b1f5387570, createdName=ms7000002110969436, createdTime=Mon Nov 06 19:23:30 CST 2023, time=2023-11-06, status=1, ipAttribution=江苏省)]

2023-12-12 ms7000002110969436 来自江苏省

各位老师号！请教一个问题：这个杂志上的文章published之后多长时间可以在web of science检索到？

37 4

展开4条回复

[GetPortalCommentsPageByObjectIdResponse(id=2179063, encodeId=e3ea21e906379, content=偏重的研究方向：肿瘤 经验分享：这期刊最近submit多久拒稿呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=152e5448879, createdName=ms4000001668897773, createdTime=Wed Jan 03 17:03:30 CST 2024, time=2024-01-03, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2175546, encodeId=1f0021e5546ce, content= 审稿人的回复：I strongly believe if the authors attempt a rewrite sentence by sentence and consider grammar the quality of the work will be improved tremendously and it will be useful article to scientific community everywhere. In its current form, I am not able to recommend this article for publication.这是拒了的意思吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dbde5575440, createdName=ms8000000268717089, createdTime=Mon Dec 18 09:37:50 CST 2023, time=2023-12-18, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2178638, encodeId=c9ba21e86387a, content=偏重的研究方向：肿瘤 经验分享：23.12.27 submit 24.1.1 仍然initial validation, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=152e5448879, createdName=ms4000001668897773, createdTime=Mon Jan 01 18:38:20 CST 2024, time=2024-01-01, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2160922, encodeId=32312160922ec, content=技术审查一个多月了，催了几次都说会催诚信团队，但至今都卡在技术审查这步，有人遇到过同样情况吗😮‍💨, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=009a8811870, createdName=ms1000000556586108, createdTime=Wed Oct 04 17:16:56 CST 2023, time=2023-10-04, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2174385, encodeId=9bf921e43850a, content=各位老师号！请教一个问题：这个杂志上的文章published之后多长时间可以在web of science检索到？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5b1f5387570, createdName=ms7000002110969436, createdTime=Tue Dec 12 08:59:12 CST 2023, time=2023-12-12, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2159908, encodeId=15552159908be, content=投稿时就要付款了吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8c7a8160924, createdName=ms5000001590163843, createdTime=Tue Sep 26 23:25:07 CST 2023, time=2023-09-26, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2148854, encodeId=489b214885495, content=审稿速度:3.0 偏重的研究方向：seer数据库;肿瘤 经验分享：投稿经验分享：总共三个审稿人，其中第2个审稿人拒稿，审稿人1和3分别给了大修意见，2周时间修回，审稿人1和3均很快finalized。然后编辑10天左右接收，感恩编辑处理速度，虽说影响因子有降，但还是很开心，希望大家都投稿顺利，遇到nice的编辑和审稿人~ 07 Apr 2023 Submitting Author submitted manuscript. 16 Jun 2023 Interactive review forum activated automatically. 30 Jun 2023 Review of Review Editor 3 finalized. 09 Jul 2023 Review of Review Editor 1 finalized. 18 Jul 2023 Article accepted for publication., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=117, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=57b84693922, createdName=gaogao, createdTime=Wed Jul 19 21:10:43 CST 2023, time=2023-07-19, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2170093, encodeId=1f9021e009306, content=偏重的研究方向：肿瘤免疫 经验分享：这个杂志未来预警的可能性大吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6a638109651, createdName=清清欢, createdTime=Tue Nov 21 22:48:23 CST 2023, time=2023-11-21, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2167854, encodeId=4120216e85470, content=审稿速度:1.0 | 投稿命中率:95.0 偏重的研究方向：肺癌 经验分享：非常快！ 27 Sep 2023 Article accepted for publication. Submitting Author re-submitted manuscript. 25 Sep 2023 Corresponding/Submitting Author is automatically requested to revise and resubmit the manuscript. Review of Reviewer 2 is finalized. Review of Reviewer 1 is finalized. 13 Sep 2023 Submitting Author submitted manuscript., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5bca6432300, createdName=ms4000000828277451, createdTime=Fri Nov 10 15:07:18 CST 2023, time=2023-11-10, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2167075, encodeId=f43d216e07557, content=目前只邀请到了一个审稿人，且这个审稿人审稿结束了，同意出版。编辑说还要邀请审稿人呢，一个审稿人不行，已经过去半个月了，还没消息。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5b1f5387570, createdName=ms7000002110969436, createdTime=Mon Nov 06 19:23:30 CST 2023, time=2023-11-06, status=1, ipAttribution=江苏省)]

2023-09-26 ms5000001590163843 来自辽宁省

投稿时就要付款了吗

69 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2179063, encodeId=e3ea21e906379, content=偏重的研究方向：肿瘤 经验分享：这期刊最近submit多久拒稿呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=152e5448879, createdName=ms4000001668897773, createdTime=Wed Jan 03 17:03:30 CST 2024, time=2024-01-03, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2175546, encodeId=1f0021e5546ce, content= 审稿人的回复：I strongly believe if the authors attempt a rewrite sentence by sentence and consider grammar the quality of the work will be improved tremendously and it will be useful article to scientific community everywhere. In its current form, I am not able to recommend this article for publication.这是拒了的意思吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dbde5575440, createdName=ms8000000268717089, createdTime=Mon Dec 18 09:37:50 CST 2023, time=2023-12-18, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2178638, encodeId=c9ba21e86387a, content=偏重的研究方向：肿瘤 经验分享：23.12.27 submit 24.1.1 仍然initial validation, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=152e5448879, createdName=ms4000001668897773, createdTime=Mon Jan 01 18:38:20 CST 2024, time=2024-01-01, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2160922, encodeId=32312160922ec, content=技术审查一个多月了，催了几次都说会催诚信团队，但至今都卡在技术审查这步，有人遇到过同样情况吗😮‍💨, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=009a8811870, createdName=ms1000000556586108, createdTime=Wed Oct 04 17:16:56 CST 2023, time=2023-10-04, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2174385, encodeId=9bf921e43850a, content=各位老师号！请教一个问题：这个杂志上的文章published之后多长时间可以在web of science检索到？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5b1f5387570, createdName=ms7000002110969436, createdTime=Tue Dec 12 08:59:12 CST 2023, time=2023-12-12, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2159908, encodeId=15552159908be, content=投稿时就要付款了吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8c7a8160924, createdName=ms5000001590163843, createdTime=Tue Sep 26 23:25:07 CST 2023, time=2023-09-26, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2148854, encodeId=489b214885495, content=审稿速度:3.0 偏重的研究方向：seer数据库;肿瘤 经验分享：投稿经验分享：总共三个审稿人，其中第2个审稿人拒稿，审稿人1和3分别给了大修意见，2周时间修回，审稿人1和3均很快finalized。然后编辑10天左右接收，感恩编辑处理速度，虽说影响因子有降，但还是很开心，希望大家都投稿顺利，遇到nice的编辑和审稿人~ 07 Apr 2023 Submitting Author submitted manuscript. 16 Jun 2023 Interactive review forum activated automatically. 30 Jun 2023 Review of Review Editor 3 finalized. 09 Jul 2023 Review of Review Editor 1 finalized. 18 Jul 2023 Article accepted for publication., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=117, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=57b84693922, createdName=gaogao, createdTime=Wed Jul 19 21:10:43 CST 2023, time=2023-07-19, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2170093, encodeId=1f9021e009306, content=偏重的研究方向：肿瘤免疫 经验分享：这个杂志未来预警的可能性大吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6a638109651, createdName=清清欢, createdTime=Tue Nov 21 22:48:23 CST 2023, time=2023-11-21, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2167854, encodeId=4120216e85470, content=审稿速度:1.0 | 投稿命中率:95.0 偏重的研究方向：肺癌 经验分享：非常快！ 27 Sep 2023 Article accepted for publication. Submitting Author re-submitted manuscript. 25 Sep 2023 Corresponding/Submitting Author is automatically requested to revise and resubmit the manuscript. Review of Reviewer 2 is finalized. Review of Reviewer 1 is finalized. 13 Sep 2023 Submitting Author submitted manuscript., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5bca6432300, createdName=ms4000000828277451, createdTime=Fri Nov 10 15:07:18 CST 2023, time=2023-11-10, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2167075, encodeId=f43d216e07557, content=目前只邀请到了一个审稿人，且这个审稿人审稿结束了，同意出版。编辑说还要邀请审稿人呢，一个审稿人不行，已经过去半个月了，还没消息。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5b1f5387570, createdName=ms7000002110969436, createdTime=Mon Nov 06 19:23:30 CST 2023, time=2023-11-06, status=1, ipAttribution=江苏省)]

2023-07-19 gaogao 来自广东省

审稿速度:3.0
偏重的研究方向：seer数据库;肿瘤
经验分享：投稿经验分享：总共三个审稿人，其中第2个审稿人拒稿，审稿人1和3分别给了大修意见，2周时间修回，审稿人1和3均很快finalized。然后编辑10天左右接收，感恩编辑处理速度，虽说影响因子有降，但还是很开心，希望大家都投稿顺利，遇到nice的编辑和审稿人~
07 Apr 2023 Submitting Author submitted manuscript.
16 Jun 2023 Interactive review forum activated automatically.
30 Jun 2023 Review of Review Editor 3 finalized.
09 Jul 2023 Review of Review Editor 1 finalized.
18 Jul 2023 Article accepted for publication.

117 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2179063, encodeId=e3ea21e906379, content=偏重的研究方向：肿瘤 经验分享：这期刊最近submit多久拒稿呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=152e5448879, createdName=ms4000001668897773, createdTime=Wed Jan 03 17:03:30 CST 2024, time=2024-01-03, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2175546, encodeId=1f0021e5546ce, content= 审稿人的回复：I strongly believe if the authors attempt a rewrite sentence by sentence and consider grammar the quality of the work will be improved tremendously and it will be useful article to scientific community everywhere. In its current form, I am not able to recommend this article for publication.这是拒了的意思吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dbde5575440, createdName=ms8000000268717089, createdTime=Mon Dec 18 09:37:50 CST 2023, time=2023-12-18, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2178638, encodeId=c9ba21e86387a, content=偏重的研究方向：肿瘤 经验分享：23.12.27 submit 24.1.1 仍然initial validation, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=152e5448879, createdName=ms4000001668897773, createdTime=Mon Jan 01 18:38:20 CST 2024, time=2024-01-01, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2160922, encodeId=32312160922ec, content=技术审查一个多月了，催了几次都说会催诚信团队，但至今都卡在技术审查这步，有人遇到过同样情况吗😮‍💨, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=009a8811870, createdName=ms1000000556586108, createdTime=Wed Oct 04 17:16:56 CST 2023, time=2023-10-04, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2174385, encodeId=9bf921e43850a, content=各位老师号！请教一个问题：这个杂志上的文章published之后多长时间可以在web of science检索到？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5b1f5387570, createdName=ms7000002110969436, createdTime=Tue Dec 12 08:59:12 CST 2023, time=2023-12-12, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2159908, encodeId=15552159908be, content=投稿时就要付款了吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8c7a8160924, createdName=ms5000001590163843, createdTime=Tue Sep 26 23:25:07 CST 2023, time=2023-09-26, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2148854, encodeId=489b214885495, content=审稿速度:3.0 偏重的研究方向：seer数据库;肿瘤 经验分享：投稿经验分享：总共三个审稿人，其中第2个审稿人拒稿，审稿人1和3分别给了大修意见，2周时间修回，审稿人1和3均很快finalized。然后编辑10天左右接收，感恩编辑处理速度，虽说影响因子有降，但还是很开心，希望大家都投稿顺利，遇到nice的编辑和审稿人~ 07 Apr 2023 Submitting Author submitted manuscript. 16 Jun 2023 Interactive review forum activated automatically. 30 Jun 2023 Review of Review Editor 3 finalized. 09 Jul 2023 Review of Review Editor 1 finalized. 18 Jul 2023 Article accepted for publication., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=117, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=57b84693922, createdName=gaogao, createdTime=Wed Jul 19 21:10:43 CST 2023, time=2023-07-19, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2170093, encodeId=1f9021e009306, content=偏重的研究方向：肿瘤免疫 经验分享：这个杂志未来预警的可能性大吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6a638109651, createdName=清清欢, createdTime=Tue Nov 21 22:48:23 CST 2023, time=2023-11-21, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2167854, encodeId=4120216e85470, content=审稿速度:1.0 | 投稿命中率:95.0 偏重的研究方向：肺癌 经验分享：非常快！ 27 Sep 2023 Article accepted for publication. Submitting Author re-submitted manuscript. 25 Sep 2023 Corresponding/Submitting Author is automatically requested to revise and resubmit the manuscript. Review of Reviewer 2 is finalized. Review of Reviewer 1 is finalized. 13 Sep 2023 Submitting Author submitted manuscript., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5bca6432300, createdName=ms4000000828277451, createdTime=Fri Nov 10 15:07:18 CST 2023, time=2023-11-10, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2167075, encodeId=f43d216e07557, content=目前只邀请到了一个审稿人，且这个审稿人审稿结束了，同意出版。编辑说还要邀请审稿人呢，一个审稿人不行，已经过去半个月了，还没消息。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5b1f5387570, createdName=ms7000002110969436, createdTime=Mon Nov 06 19:23:30 CST 2023, time=2023-11-06, status=1, ipAttribution=江苏省)]

2023-11-21 清清欢来自江西省

偏重的研究方向：肿瘤免疫
经验分享：这个杂志未来预警的可能性大吗？

47 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2179063, encodeId=e3ea21e906379, content=偏重的研究方向：肿瘤 经验分享：这期刊最近submit多久拒稿呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=152e5448879, createdName=ms4000001668897773, createdTime=Wed Jan 03 17:03:30 CST 2024, time=2024-01-03, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2175546, encodeId=1f0021e5546ce, content= 审稿人的回复：I strongly believe if the authors attempt a rewrite sentence by sentence and consider grammar the quality of the work will be improved tremendously and it will be useful article to scientific community everywhere. In its current form, I am not able to recommend this article for publication.这是拒了的意思吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dbde5575440, createdName=ms8000000268717089, createdTime=Mon Dec 18 09:37:50 CST 2023, time=2023-12-18, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2178638, encodeId=c9ba21e86387a, content=偏重的研究方向：肿瘤 经验分享：23.12.27 submit 24.1.1 仍然initial validation, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=152e5448879, createdName=ms4000001668897773, createdTime=Mon Jan 01 18:38:20 CST 2024, time=2024-01-01, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2160922, encodeId=32312160922ec, content=技术审查一个多月了，催了几次都说会催诚信团队，但至今都卡在技术审查这步，有人遇到过同样情况吗😮‍💨, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=009a8811870, createdName=ms1000000556586108, createdTime=Wed Oct 04 17:16:56 CST 2023, time=2023-10-04, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2174385, encodeId=9bf921e43850a, content=各位老师号！请教一个问题：这个杂志上的文章published之后多长时间可以在web of science检索到？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5b1f5387570, createdName=ms7000002110969436, createdTime=Tue Dec 12 08:59:12 CST 2023, time=2023-12-12, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2159908, encodeId=15552159908be, content=投稿时就要付款了吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8c7a8160924, createdName=ms5000001590163843, createdTime=Tue Sep 26 23:25:07 CST 2023, time=2023-09-26, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2148854, encodeId=489b214885495, content=审稿速度:3.0 偏重的研究方向：seer数据库;肿瘤 经验分享：投稿经验分享：总共三个审稿人，其中第2个审稿人拒稿，审稿人1和3分别给了大修意见，2周时间修回，审稿人1和3均很快finalized。然后编辑10天左右接收，感恩编辑处理速度，虽说影响因子有降，但还是很开心，希望大家都投稿顺利，遇到nice的编辑和审稿人~ 07 Apr 2023 Submitting Author submitted manuscript. 16 Jun 2023 Interactive review forum activated automatically. 30 Jun 2023 Review of Review Editor 3 finalized. 09 Jul 2023 Review of Review Editor 1 finalized. 18 Jul 2023 Article accepted for publication., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=117, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=57b84693922, createdName=gaogao, createdTime=Wed Jul 19 21:10:43 CST 2023, time=2023-07-19, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2170093, encodeId=1f9021e009306, content=偏重的研究方向：肿瘤免疫 经验分享：这个杂志未来预警的可能性大吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6a638109651, createdName=清清欢, createdTime=Tue Nov 21 22:48:23 CST 2023, time=2023-11-21, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2167854, encodeId=4120216e85470, content=审稿速度:1.0 | 投稿命中率:95.0 偏重的研究方向：肺癌 经验分享：非常快！ 27 Sep 2023 Article accepted for publication. Submitting Author re-submitted manuscript. 25 Sep 2023 Corresponding/Submitting Author is automatically requested to revise and resubmit the manuscript. Review of Reviewer 2 is finalized. Review of Reviewer 1 is finalized. 13 Sep 2023 Submitting Author submitted manuscript., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5bca6432300, createdName=ms4000000828277451, createdTime=Fri Nov 10 15:07:18 CST 2023, time=2023-11-10, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2167075, encodeId=f43d216e07557, content=目前只邀请到了一个审稿人，且这个审稿人审稿结束了，同意出版。编辑说还要邀请审稿人呢，一个审稿人不行，已经过去半个月了，还没消息。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5b1f5387570, createdName=ms7000002110969436, createdTime=Mon Nov 06 19:23:30 CST 2023, time=2023-11-06, status=1, ipAttribution=江苏省)]

2023-11-10 ms4000000828277451 来自山东省

审稿速度:1.0 | 投稿命中率:95.0
偏重的研究方向：肺癌
经验分享：非常快！
27 Sep 2023
Article accepted for publication.
Submitting Author re-submitted manuscript.
25 Sep 2023
Corresponding/Submitting Author is automatically requested to revise and resubmit the manuscript.
Review of Reviewer 2 is finalized.
Review of Reviewer 1 is finalized.
13 Sep 2023
Submitting Author submitted manuscript.

60 0

[GetPortalCommentsPageByObjectIdResponse(id=2179063, encodeId=e3ea21e906379, content=偏重的研究方向：肿瘤 经验分享：这期刊最近submit多久拒稿呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=152e5448879, createdName=ms4000001668897773, createdTime=Wed Jan 03 17:03:30 CST 2024, time=2024-01-03, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2175546, encodeId=1f0021e5546ce, content= 审稿人的回复：I strongly believe if the authors attempt a rewrite sentence by sentence and consider grammar the quality of the work will be improved tremendously and it will be useful article to scientific community everywhere. In its current form, I am not able to recommend this article for publication.这是拒了的意思吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dbde5575440, createdName=ms8000000268717089, createdTime=Mon Dec 18 09:37:50 CST 2023, time=2023-12-18, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2178638, encodeId=c9ba21e86387a, content=偏重的研究方向：肿瘤 经验分享：23.12.27 submit 24.1.1 仍然initial validation, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=152e5448879, createdName=ms4000001668897773, createdTime=Mon Jan 01 18:38:20 CST 2024, time=2024-01-01, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2160922, encodeId=32312160922ec, content=技术审查一个多月了，催了几次都说会催诚信团队，但至今都卡在技术审查这步，有人遇到过同样情况吗😮‍💨, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=009a8811870, createdName=ms1000000556586108, createdTime=Wed Oct 04 17:16:56 CST 2023, time=2023-10-04, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2174385, encodeId=9bf921e43850a, content=各位老师号！请教一个问题：这个杂志上的文章published之后多长时间可以在web of science检索到？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5b1f5387570, createdName=ms7000002110969436, createdTime=Tue Dec 12 08:59:12 CST 2023, time=2023-12-12, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2159908, encodeId=15552159908be, content=投稿时就要付款了吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8c7a8160924, createdName=ms5000001590163843, createdTime=Tue Sep 26 23:25:07 CST 2023, time=2023-09-26, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2148854, encodeId=489b214885495, content=审稿速度:3.0 偏重的研究方向：seer数据库;肿瘤 经验分享：投稿经验分享：总共三个审稿人，其中第2个审稿人拒稿，审稿人1和3分别给了大修意见，2周时间修回，审稿人1和3均很快finalized。然后编辑10天左右接收，感恩编辑处理速度，虽说影响因子有降，但还是很开心，希望大家都投稿顺利，遇到nice的编辑和审稿人~ 07 Apr 2023 Submitting Author submitted manuscript. 16 Jun 2023 Interactive review forum activated automatically. 30 Jun 2023 Review of Review Editor 3 finalized. 09 Jul 2023 Review of Review Editor 1 finalized. 18 Jul 2023 Article accepted for publication., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=117, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=57b84693922, createdName=gaogao, createdTime=Wed Jul 19 21:10:43 CST 2023, time=2023-07-19, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2170093, encodeId=1f9021e009306, content=偏重的研究方向：肿瘤免疫 经验分享：这个杂志未来预警的可能性大吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=47, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6a638109651, createdName=清清欢, createdTime=Tue Nov 21 22:48:23 CST 2023, time=2023-11-21, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2167854, encodeId=4120216e85470, content=审稿速度:1.0 | 投稿命中率:95.0 偏重的研究方向：肺癌 经验分享：非常快！ 27 Sep 2023 Article accepted for publication. Submitting Author re-submitted manuscript. 25 Sep 2023 Corresponding/Submitting Author is automatically requested to revise and resubmit the manuscript. Review of Reviewer 2 is finalized. Review of Reviewer 1 is finalized. 13 Sep 2023 Submitting Author submitted manuscript., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5bca6432300, createdName=ms4000000828277451, createdTime=Fri Nov 10 15:07:18 CST 2023, time=2023-11-10, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2167075, encodeId=f43d216e07557, content=目前只邀请到了一个审稿人，且这个审稿人审稿结束了，同意出版。编辑说还要邀请审稿人呢，一个审稿人不行，已经过去半个月了，还没消息。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5b1f5387570, createdName=ms7000002110969436, createdTime=Mon Nov 06 19:23:30 CST 2023, time=2023-11-06, status=1, ipAttribution=江苏省)]

2023-11-06 ms7000002110969436 来自江苏省

目前只邀请到了一个审稿人，且这个审稿人审稿结束了，同意出版。编辑说还要邀请审稿人呢，一个审稿人不行，已经过去半个月了，还没消息。

36 0

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务